CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
We have now added a new section called the "Assay History List" to the "At A Gla...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...